The Proteasome as Molecular Target of Grape Polyphenols

蛋白酶体作为葡萄多酚的分子靶标

基本信息

  • 批准号:
    6952307
  • 负责人:
  • 金额:
    $ 7.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-09-30 至 2007-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our long-term objective is to discover novel potent, specific cancer preventative and anticancer agents with no cytotoxicity. Recent results from in vitro, in vivo and clinical trials have supported the use of proteasome inhibitors as potential novel anticancer drugs. We have found that natural and synthetic green tea polyphenols with an ester bond are potent and specific proteasomal chymotrypsin-like inhibitors, while those without an ester bond are inactive. Most recently, we have reported that grape extract inhibits the proteasomal chymotrypsin-like activity in leukemia Jurkat T cell extract and intact Jurkat T cells, associated with apoptosis induction. Furthermore, grape extract induces the appearance of spherical cells preferentially in prostate cancer PC-3 over normal NIH 3T3 cell line. Our findings suggest that the proteasome is a cancer related molecular target for grape antioxidant components. Based on these results, we hypothesize that inhibition of the proteasome activity by some antioxidant polyphenolic compounds contributes to the prostate cancer-preventative activities of grapes. To address this hypothesis, we propose the following Three Specific Aims. Specific Aim 1 is to evaluate potency and selectivity of several grape polyphenolic compounds to inhibit the proteasome activity using purified 20S proteasome, prostate cancer cell extracts, and intact prostate cancer cells. Specific Aim 2 is to evaluate the apoptosis-inducing potency of these polyphenolic compounds in human prostate cancer and normal cells. Specific Aim 3 is to determine whether the abilities of these grape antioxidant polyphenolic compounds to inhibit the proteasome activity and to induce apoptosis correlate with their cancer-preventative activity in vivo using nude mice bearing human prostate cancer cells. These studies should help develop a fundamental understanding about how consumption of grapes and other fruits and vegetables prevents cancer, and discover potent, specific and stable polyphenol proteasome inhibitors with no or little toxicity for the prevention of prostate and other cancers.
描述(由申请人提供):

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy.
  • DOI:
    10.1016/j.ccr.2009.01.032
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    20.6
  • 作者:
    Milacic V;Dou QP
  • 通讯作者:
    Dou QP
Relationship between the methylation status of dietary flavonoids and their growth-inhibitory and apoptosis-inducing activities in human cancer cells.
  • DOI:
    10.1002/jcb.21853
  • 发表时间:
    2008-10-01
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Landis-Piwowar, Kristin R.;Milacic, Vesna;Dou, Q. Ping
  • 通讯作者:
    Dou, Q. Ping
Tea polyphenols and their roles in cancer prevention and chemotherapy.
Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo.
Withaferin A 在体外和体内抑制间皮瘤中的蛋白酶体活性。
  • DOI:
    10.1371/journal.pone.0041214
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Yang,Huanjie;Wang,Ying;Cheryan,VinoT;Wu,Wenjuan;Cui,CindyQiuzhi;Polin,LisaA;Pass,HarveyI;Dou,QPing;Rishi,ArunK;Wali,Anil
  • 通讯作者:
    Wali,Anil
The challenge of developing green tea polyphenols as therapeutic agents.
  • DOI:
    10.1007/s10787-008-8031-x
  • 发表时间:
    2008-10
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Huo, C.;Wan, S. B.;Lam, W. H.;Li, L.;Wang, Z.;Landis-Piwowar, K. R.;Chen, D.;Dou, Q. P.;Chan, T. H.
  • 通讯作者:
    Chan, T. H.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

QING PING DOU其他文献

QING PING DOU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('QING PING DOU', 18)}}的其他基金

(PQA1) Regulation of Metformin Response by Breast Cancer Associated Gene 2 (BCA2)
(PQA1) 乳腺癌相关基因 2 (BCA2) 对二甲双胍反应的调节
  • 批准号:
    8848363
  • 财政年份:
    2014
  • 资助金额:
    $ 7.55万
  • 项目类别:
(PQA1) Regulation of Metformin Response by Breast Cancer Associated Gene 2 (BCA2)
(PQA1) 乳腺癌相关基因 2 (BCA2) 对二甲双胍反应的调节
  • 批准号:
    8685444
  • 财政年份:
    2014
  • 资助金额:
    $ 7.55万
  • 项目类别:
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
多态COMT、茶多酚和蛋白酶体在癌症预防中的作用
  • 批准号:
    7909204
  • 财政年份:
    2009
  • 资助金额:
    $ 7.55万
  • 项目类别:
The BCA2 Ubiquitin E3 Ligase as a Target in Breast Cancer
BCA2 泛素 E3 连接酶作为乳腺癌的靶标
  • 批准号:
    7848072
  • 财政年份:
    2007
  • 资助金额:
    $ 7.55万
  • 项目类别:
The BCA2 Ubiquitin E3 Ligase as a Target in Breast Cancer
BCA2 泛素 E3 连接酶作为乳腺癌的靶标
  • 批准号:
    8072551
  • 财政年份:
    2007
  • 资助金额:
    $ 7.55万
  • 项目类别:
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
多态COMT、茶多酚和蛋白酶体在癌症预防中的作用
  • 批准号:
    7578945
  • 财政年份:
    2006
  • 资助金额:
    $ 7.55万
  • 项目类别:
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
多态COMT、茶多酚和蛋白酶体在癌症预防中的作用
  • 批准号:
    7070198
  • 财政年份:
    2006
  • 资助金额:
    $ 7.55万
  • 项目类别:
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
多态COMT、茶多酚和蛋白酶体在癌症预防中的作用
  • 批准号:
    7355585
  • 财政年份:
    2006
  • 资助金额:
    $ 7.55万
  • 项目类别:
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
多态COMT、茶多酚和蛋白酶体在癌症预防中的作用
  • 批准号:
    7774417
  • 财政年份:
    2006
  • 资助金额:
    $ 7.55万
  • 项目类别:
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
多态COMT、茶多酚和蛋白酶体在癌症预防中的作用
  • 批准号:
    7221981
  • 财政年份:
    2006
  • 资助金额:
    $ 7.55万
  • 项目类别:

相似海外基金

Phenolic antioxidants as tumor radio/chemosensitizers
酚类抗氧化剂作为肿瘤放射/化学增敏剂
  • 批准号:
    6924874
  • 财政年份:
    2005
  • 资助金额:
    $ 7.55万
  • 项目类别:
Chamomile as Medicine for Prostate cancer
洋甘菊作为治疗前列腺癌的药物
  • 批准号:
    7121483
  • 财政年份:
    2005
  • 资助金额:
    $ 7.55万
  • 项目类别:
Chamomile as Medicine for Prostate cancer
洋甘菊作为治疗前列腺癌的药物
  • 批准号:
    6898568
  • 财政年份:
    2005
  • 资助金额:
    $ 7.55万
  • 项目类别:
Phenolic antioxidants as tumor radio/chemosensitizers
酚类抗氧化剂作为肿瘤放射/化学增敏剂
  • 批准号:
    7049385
  • 财政年份:
    2005
  • 资助金额:
    $ 7.55万
  • 项目类别:
Peroxiredoxin 1 in radiotherapy of lung cancer
过氧化还原蛋白1在肺癌放疗中的应用
  • 批准号:
    6814987
  • 财政年份:
    2004
  • 资助金额:
    $ 7.55万
  • 项目类别:
The Proteasome as Molecular Target of Grape Polyphenols
蛋白酶体作为葡萄多酚的分子靶标
  • 批准号:
    6877457
  • 财政年份:
    2004
  • 资助金额:
    $ 7.55万
  • 项目类别:
DNA Damage: Fruit & Vegetable Effects in a Feeding Trial
DNA 损伤:水果
  • 批准号:
    6783761
  • 财政年份:
    2004
  • 资助金额:
    $ 7.55万
  • 项目类别:
Nanospheres as Vehicles for Treatment of Neuroblastoma
纳米球作为治疗神经母细胞瘤的载体
  • 批准号:
    6710556
  • 财政年份:
    2004
  • 资助金额:
    $ 7.55万
  • 项目类别:
Peroxiredoxin 1 in radiotherapy of lung cancer
过氧化还原蛋白1在肺癌放射治疗中的应用
  • 批准号:
    7095240
  • 财政年份:
    2004
  • 资助金额:
    $ 7.55万
  • 项目类别:
Peroxiredoxin 1 in radiotherapy of lung cancer
过氧化还原蛋白1在肺癌放疗中的应用
  • 批准号:
    6928549
  • 财政年份:
    2004
  • 资助金额:
    $ 7.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了